(UroToday.com) The annual Young Urologic Oncologists (YUO) program featured the top two outstanding poster presentations, highlighted by full presentations. The first presentation was by Dr. Neil Mendhiratta, PGY-5 resident at the UCLA Department of Urology, entitled “Decisional Regret and Financial Toxicity Among Patients with Benign Renal Masses.” Treatment of benign renal masses may often be unnecessary yet can lead to significant costs, morbidity, and mortality. Indeed, the cost of benign tumor resections includes $55,000 per hospitalization and $153 million annually. In this population, individual burdens such as decisional regret and financial costs associated with treatment are not well understood. The aim of this study was to assess decisional regret and financial toxicity among patients diagnosed with benign renal masses and to identify patient and tumor-associated predictors of each.